SCHEMBL24229760

SCHEMBL24229760

C[Si](C)(C)CCOCn1c(N2CCc3ccc(O)cc3C2)nc2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24229632 0.90 HDAC6 (0.37) —
SCHEMBL24229758 0.86 HRH3 (0.47) —
SCHEMBL24239299 0.86 HDAC6 (0.33) —
SCHEMBL2674062 0.78 — —
SCHEMBL24229492 0.78 HRH3 (0.44) —
SCHEMBL24229708 0.77 HRH3 (0.43) —
SCHEMBL23122630 0.76 KDM4E (0.48) —
SCHEMBL24229761 0.76 BRAF (0.47) —
SCHEMBL29052787 0.75 RAF1 (0.33) —
SCHEMBL24229635 0.75 HRH3 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858930-B2 Fused bicyclic RAF inhibitors and methods for use thereof JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2024-01-02 — — US disclosed
US-11858930-B2 Fused bicyclic RAF inhibitors and methods for use thereof JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2024-01-02 — — US disclosed
WO-2022023447-A2 FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2022-02-03 — — WO disclosed
US-20220033398-A1 FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2022-02-03 — — US disclosed
Send feedback